Microfluidics offers several key benefits for cancer research and treatment:
High-throughput screening: Capable of analyzing numerous samples simultaneously, microfluidic devices can rapidly screen for potential cancer therapeutics or biomarkers. Single-cell analysis: This technology allows for the examination of individual cancer cells, providing insights into tumor heterogeneity and aiding in the understanding of cancer progression and resistance mechanisms. Precision medicine: Microfluidics can facilitate the development of tailored therapeutic approaches by enabling the precise manipulation and analysis of patient-derived cells.
